Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD
This study has been completed.
Study NCT00117182 Information provided by Pharmaxis
First Received: June 30, 2005 Last Updated: August 27, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lung Diseases, Obstructive
Additional conditions recognized in this trial
Lung Diseases
More general conditions related to this trial
Respiratory Tract Diseases
Interventions listed in this trial
Dry powder mannitol
Ipratropium bromide 80mcg
Salbutamol 400mcg
Additional drug interventions recognized in this trial
Albuterol
Budesonide
Ipratropium
Mannitol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Cholinergic Agents
Cholinergic Antagonists
Diuretics
Diuretics, Osmotic
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Respiratory System Agents
Therapeutic Uses
Tocolytic Agents
Sponsors listed in this trial
Pharmaxis
Back to top of Main Content
